Provinces Warn Ottawa Over CETA IP Provisions
One Comment
Recent Posts
A Standard That Doesn’t Exist: Parliamentary Secretary for Justice Offers Misleading Defence of Bill C-22’s Lower Threshold for Subscriber Information 
More Surveillance Demands to Come?: Government Admits Bill C-22’s Lawful Access Provisions Could Be Expanded 
Win, Lose or Draw?: The Federal Court of Appeal Overrules a Key Copyright Case on Procedural Grounds 
The Lawful Access Debate Begins: Canadians Should Pay Attention to What the Government Isn’t Saying 
The Global Battle for Data Control: How the 2026 U.S. Report on Trade Barriers Targets Data Sovereignty Worldwide
deliberately adding cost to health care
is precisely why Canada should not enter into this agreement. Also, the lack of transparency in the deal is troubling. Just whom, other multinational pharmaceutical companies and myopic French farmers, is this agreement benefiting? Why would we enter such a costly agreement especially when both federal and provincial levels of government are running large deficits? The government needs to answer those question directly.